{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:57:58Z","timestamp":1785448678498,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    While prostate cancer (PrCa) is highly heritable, the genes associated with PrCa survival after diagnosis remain poorly understood. We aimed to identify genes associated with PrCa-specific survival through transcriptome-wide association studies (TWAS) using genetic predictors of gene expression in the prostate. We used the Transcriptome-Integrated Genetic Association Resource (TIGAR) to train expression prediction models separately using normal prostate, primary tumor, and metastatic tumor tissues. We performed TWAS using these models in data from the Malm\u00f6 Diet and Cancer (MDC) study (discovery) and Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial (validation). We identified and validated seven genes associated with PrCa-specific survival at a common locus on chromosome 1. We found two genes using prediction models from normal prostate tissues and five with models from metastatic tumor tissues. Elevated\n                    <jats:italic>RCC1<\/jats:italic>\n                    expression is linked to a shorter time to biochemical recurrence, while higher\n                    <jats:italic>PHACTR4<\/jats:italic>\n                    expression was observed in tumors with a higher Gleason grade. The study is limited to European ancestry and can only show associations. Further research across other populations and experiments to establish causality will be needed. Our multi-tissue study identified novel genes associated with PrCa survival, particularly\n                    <jats:italic>RCC1<\/jats:italic>\n                    and\n                    <jats:italic>PHACTR4<\/jats:italic>\n                    , providing new insights for potential genomic markers for PrCa survival.\n                  <\/jats:p>","DOI":"10.1038\/s41431-026-02147-1","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:39:33Z","timestamp":1781951973000},"page":"1147-1155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival"],"prefix":"10.1038","volume":"34","author":[{"given":"Weijia","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-7846","authenticated-orcid":false,"given":"Hans","family":"Lilja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0085-1190","authenticated-orcid":false,"given":"Weiva","family":"Sieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-6244","authenticated-orcid":false,"given":"Xiaoyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-5391","authenticated-orcid":false,"given":"Robert J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"2147_CR1","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"2147_CR2","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/jnci\/djm153","volume":"99","author":"GP Haas","year":"2007","unstructured":"Haas GP, Delongchamps NB, Jones RF, Chandan V, Serio AM, Vickers AJ, et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst. 2007;99:1484\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"2147_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/JU.0000000000002696","volume":"208","author":"M Fr\u00e5nlund","year":"2022","unstructured":"Fr\u00e5nlund M, M\u00e5nsson M, Godtman RA, Aus G, Holmberg E, Kollberg KS, et al. Results from 22 years of Followup in the G\u00f6teborg Randomized Population-Based Prostate Cancer Screening Trial. J Urol. 2022;208:292\u2013300.","journal-title":"J Urol"},{"key":"2147_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jamaoncol.2024.5381","volume":"11","author":"KAB Goddard","year":"2025","unstructured":"Goddard KAB, Feuer EJ, Mandelblatt JS, Meza R, Holford TR, Jeon J, et al. Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. JAMA Oncol. 2025;11:162\u20137.","journal-title":"JAMA Oncol"},{"key":"2147_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78\u201385.","journal-title":"N Engl J Med"},{"key":"2147_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jama.2015.17703","volume":"315","author":"LA Mucci","year":"2016","unstructured":"Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA. 2016;315:68\u201376.","journal-title":"JAMA"},{"key":"2147_CR7","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","volume":"55","author":"A Wang","year":"2023","unstructured":"Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. 2023;55:2065\u201374.","journal-title":"Nat Genet"},{"key":"2147_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10808-7","volume":"10","author":"NC Emami","year":"2019","unstructured":"Emami NC, Kachuri L, Meyers TJ, Das R, Hoffman JD, Hoffmann TJ, et al. Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms. Nat Commun. 2019;10:3107.","journal-title":"Nat Commun"},{"key":"2147_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/bjc.2015.199","volume":"113","author":"J Sullivan","year":"2015","unstructured":"Sullivan J, Kopp R, Stratton K, Manschreck C, Corines M, Rau-Murthy R, et al. An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality. Br J Cancer. 2015;113:166\u201372.","journal-title":"Br J Cancer"},{"key":"2147_CR10","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1158\/1078-0432.CCR-10-0028","volume":"16","author":"DJ Gallagher","year":"2010","unstructured":"Gallagher DJ, Vijai J, Cronin AM, Bhatia J, Vickers AJ, Gaudet MM, et al. Susceptibility loci associated with prostate cancer progression and mortality. Clin Cancer Res J Am Assoc Cancer Res. 2010;16:2819\u201332.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"2147_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S1470-2045(07)70282-6","volume":"8","author":"LS Lindstr\u00f6m","year":"2007","unstructured":"Lindstr\u00f6m LS, Hall P, Hartman M, Wiklund F, Gr\u00f6nberg H, Czene K. Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol. 2007;8:1001\u20136.","journal-title":"Lancet Oncol"},{"key":"2147_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00345-011-0801-1","volume":"30","author":"K Hemminki","year":"2012","unstructured":"Hemminki K. Familial risk and familial survival in prostate cancer. World J Urol. 2012;30:143\u20138.","journal-title":"World J Urol"},{"key":"2147_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.eururo.2018.06.021","volume":"74","author":"W Li","year":"2018","unstructured":"Li W, Middha M, Bicak M, Sjoberg DD, Vertosick E, Dahlin A, et al. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival. Eur Urol. 2018;74:710\u20139.","journal-title":"Eur Urol"},{"key":"2147_CR14","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330.","journal-title":"Science"},{"key":"2147_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma Oxf Engl. 2010;26:139\u201340.","journal-title":"Bioinforma Oxf Engl"},{"key":"2147_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ajhg.2019.05.018","volume":"105","author":"S Nagpal","year":"2019","unstructured":"Nagpal S, Meng X, Epstein MP, Tsoi LC, Patrick M, Gibson G, et al. TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex Traits. Am J Hum Genet. 2019;105:258\u201366.","journal-title":"Am J Hum Genet"},{"key":"2147_CR17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","unstructured":"Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015;163:1011\u201325.","journal-title":"Cell"},{"key":"2147_CR18","doi-asserted-by":"publisher","first-page":"e1008500","DOI":"10.1371\/journal.pgen.1008500","volume":"15","author":"MH Kowalski","year":"2019","unstructured":"Kowalski MH, Qian H, Hou Z, Rosen JD, Tapia AL, Shan Y, et al. Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic\/Latino populations. PLoS Genet. 2019;15:e1008500.","journal-title":"PLoS Genet"},{"key":"2147_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","volume":"174","author":"DA Quigley","year":"2018","unstructured":"Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, et al. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018;174:758\u201369.e9.","journal-title":"Cell"},{"key":"2147_CR20","doi-asserted-by":"publisher","first-page":"e68141","DOI":"10.1371\/journal.pone.0068141","volume":"8","author":"S Mostafavi","year":"2013","unstructured":"Mostafavi S, Battle A, Zhu X, Urban AE, Levinson D, Montgomery SB, et al. Normalizing RNA-Sequencing Data by Modeling Hidden Covariates with Prior Knowledge. PLoS One. 2013;8:e68141.","journal-title":"PLoS One"},{"key":"2147_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03621-1","volume":"9","author":"Barbeira","year":"2018","unstructured":"Barbeira, Dickinson AN, Bonazzola SP, Zheng R, Wheeler HE J, Torres JM, et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018;9:1825.","journal-title":"Nat Commun"},{"key":"2147_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Stat Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2147_CR23","volume":"4","author":"X Sheng","year":"2023","unstructured":"Sheng X, Xia L, Cahoon JL, Conti DV, Haiman CA, Kachuri L, et al. Inverted genomic regions between reference genome builds in humans impact imputation accuracy and decrease the power of association testing. HGG Adv. 2023;4:100159.","journal-title":"HGG Adv"},{"key":"2147_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590:290\u20139.","journal-title":"Nature"},{"key":"2147_CR25","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das S, Forer L, Sch\u00f6nherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284\u20137.","journal-title":"Nat Genet"},{"key":"2147_CR26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/bioinformatics\/btu704","volume":"31","author":"C Fuchsberger","year":"2015","unstructured":"Fuchsberger C, Abecasis GR, Hinds DA. minimac2: faster genotype imputation. Bioinforma Oxf Engl. 2015;31:782\u20134.","journal-title":"Bioinforma Oxf Engl"},{"key":"2147_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"2147_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5835","volume":"5","author":"S Carmi","year":"2014","unstructured":"Carmi S, Hui KY, Kochav E, Liu X, Xue J, Grady F, et al. Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nat Commun. 2014;5:4835.","journal-title":"Nat Commun"},{"key":"2147_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904\u20139.","journal-title":"Nat Genet"},{"key":"2147_CR30","doi-asserted-by":"publisher","unstructured":"Wreede LCD, Fiocco M, Putter H. mstate: An R Package for the Analysis of Competing Risks and Multi-State Models. J Stat Softw. 2011;38. https:\/\/doi.org\/10.18637\/jss.v038.i07.","DOI":"10.18637\/jss.v038.i07"},{"key":"2147_CR31","doi-asserted-by":"publisher","first-page":"e1009440","DOI":"10.1371\/journal.pgen.1009440","volume":"17","author":"C Wallace","year":"2021","unstructured":"Wallace C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet. 2021;17:e1009440.","journal-title":"PLoS Genet"},{"key":"2147_CR32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/rssb.12388","volume":"82","author":"G Wang","year":"2020","unstructured":"Wang G, Sarkar A, Carbonetto P, Stephens M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J R Stat Soc Ser B Stat Methodol. 2020;82:1273\u20131300.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2147_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ebiom.2017.02.022","volume":"17","author":"MJ Dunning","year":"2017","unstructured":"Dunning MJ, Vowler SL, Lalonde E, Ross-Adams H, Boutros P, Mills IG, et al. Mining Human Prostate Cancer Datasets: The \u2018camcAPP\u2019 Shiny App. EBioMedicine. 2017;17:5\u20136.","journal-title":"EBioMedicine"},{"key":"2147_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11\u201322.","journal-title":"Cancer Cell"},{"key":"2147_CR35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ebiom.2015.07.017","volume":"2","author":"H Ross-Adams","year":"2015","unstructured":"Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. EBioMedicine. 2015;2:1133\u201344.","journal-title":"EBioMedicine"},{"key":"2147_CR36","doi-asserted-by":"publisher","unstructured":"Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Softw. 2010;36. https:\/\/doi.org\/10.18637\/jss.v036.i03.","DOI":"10.18637\/jss.v036.i03"},{"key":"2147_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1131-9","volume":"18","author":"M van Iterson","year":"2017","unstructured":"van Iterson M, van Zwet EW, Consortium BIOS, Heijmans BT. Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution. Genome Biol. 2017;18:19.","journal-title":"Genome Biol"},{"key":"2147_CR38","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.bbamcr.2008.03.015","volume":"1783","author":"O Hadjebi","year":"2008","unstructured":"Hadjebi O, Casas-Terradellas E, Garcia-Gonzalo FR, Rosa JL. The RCC1 superfamily: from genes, to function, to disease. Biochim Biophys Acta. 2008;1783:1467\u201379.","journal-title":"Biochim Biophys Acta"},{"key":"2147_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fmolb.2020.00225","volume":"7","author":"X Ren","year":"2020","unstructured":"Ren X, Jiang K, Zhang F. The Multifaceted Roles of RCC1 in Tumorigenesis. Front Mol Biosci. 2020;7:225.","journal-title":"Front Mol Biosci"},{"key":"2147_CR40","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41417-023-00655-6","volume":"30","author":"R Garg","year":"2023","unstructured":"Garg R, Endzhievskaya S, Williamson M. B-type Plexins promote the GTPase activity of Ran to affect androgen receptor nuclear translocation in prostate cancer. Cancer Gene Ther. 2023;30:1513\u201323.","journal-title":"Cancer Gene Ther"},{"key":"2147_CR41","doi-asserted-by":"publisher","first-page":"E407","DOI":"10.1073\/pnas.1221385110","volume":"110","author":"NL Solimini","year":"2013","unstructured":"Solimini NL, Liang AC, Xu C, Pavlova NN, Xu Q, Davoli T, et al. STOP gene Phactr4 is a tumor suppressor. Proc Natl Acad Sci USA. 2013;110:E407\u2013414.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2147_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.devcel.2007.04.018","volume":"13","author":"T-H Kim","year":"2007","unstructured":"Kim T-H, Goodman J, Anderson KV, Niswander L. Phactr4 regulates neural tube and optic fissure closure by controlling PP1-, Rb-, and E2F1-regulated cell-cycle progression. Dev Cell. 2007;13:87\u2013102.","journal-title":"Dev Cell"},{"key":"2147_CR43","first-page":"3392","volume":"20","author":"F Cao","year":"2016","unstructured":"Cao F, Liu M, Zhang Q-Z, Hao R. PHACTR4 regulates proliferation, migration and invasion of human hepatocellular carcinoma by inhibiting IL-6\/Stat3 pathway. Eur Rev Med Pharm Sci. 2016;20:3392\u20139.","journal-title":"Eur Rev Med Pharm Sci"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02147-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:03:02Z","timestamp":1785445382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02147-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2147"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02147-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7095601\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HL is named on a patent for a statistical method to detect prostate cancer commercialized by OPKO Health (4KScore). HL receives royalties from sales of the test, and has stock in OPKO Health. HL serves on the Scientific Advisory Board for Fujirebio Diagnostics Inc and owns stock in Diaprost AB and Acousort AB.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was reviewed and approved by the Institutional Review Board of the Icahn School of Medicine at Mount Sinai (STUDY-20-01538). Informed consent was obtained from all subjects.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}